Tone mix
Week by week 52 weeks
Share of NanoViricides Inc.'s 167 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 25, 2025 · tone 0NanoViricides Reports NV-387's Anti-Inflammatory Effects-91
- Week of May 12, 2025 · tone -20NanoViricides: Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution-68
- Week of Oct 20, 2025 · tone +99A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus+64
- Week of Jul 7, 2025 · tone +100NanoViricides (NNVC) Accelerates MPox Drug Development, Citing Strong Business and Public Health Case+59
- Week of Jan 19, 2026 · tone 0NanoViricides to Present at the 3rd Annual DealFlow Discovery Conference-57
- Week of Sep 8, 2025 · tone 0RETRANSMISSION: NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025-56
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about NanoViricides Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | +94 |
| Last 30 sessions | 15 | +46 |
| Last 90 sessions | 35 | +67 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone +97: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.newjerseytelegraph.com · 6 outletsAs Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricidesPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides | www.newjerseytelegraph.com | 6 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone +91: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.pr-inside.com · 1 outletNanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has ...Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has ... | www.pr-inside.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.tennesseedaily.com · 4 outletsPhase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricidesPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides | www.tennesseedaily.com | 4 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.newjerseytelegraph.com · 3 outletsNanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026Neutral
- www.pr-inside.com · 1 outletNanoViricides Presenting at NIBA's 153rd Investment Conference in Fort ...Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026 | www.newjerseytelegraph.com | 3 | Neutral |
| NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort ... | www.pr-inside.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 6, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.newjerseytelegraph.com · 3 outletsNanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 LivesNeutral
- www.finanznachrichten.de · 1 outletNanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives | www.newjerseytelegraph.com | 3 | Neutral |
| NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026 | www.finanznachrichten.de | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about NanoViricides Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.